Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study
- PMID: 12426677
- DOI: 10.1007/s00066-002-0939-2
Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study
Abstract
Background: Local failure is the one of the most frequent cause of tumor related death in locally advanced non-small cell lung cancer (LAD-NSCLC). Dose escalation has the promise of increased loco-regional tumor control but is limited by the tolerances of critical organs.
Patients and methods: To evaluate the potential of IMRT in comparison to conventional three-dimensional conformal planning (3DCRT) dose constraints were defined: Maximum dose (D(max)) to spinal cord < 48 Gy, mean lung dose </= 24 Gy, D(max) esophagus > 70 Gy in not more than 5 cm of the total length. For ten patients two plans were compared: (1) 3DCRT with 5 weekly fractions (SD) of 2 Gy to a total dose (TD) of 50 Gy to the planning target volume of second order (PTV2). If the tolerance of the critical organs was not exceeded, patients get a boost plan with a higher TD to the PTV1. (2) IMRT: concomitant boost with 5 weekly SD of 2 Gy (PTV1) and 1.5 Gy to a partial (p)PTV (pPTV=PTV2 profile of a line PTV1) to a TD of 51 Gy to the pPTV and 68 Gy to the PTV1. If possible, patients get a boost plan to the PTV1 with 5 weekly SD of 2 Gy to the highest possibly TD.
Results: Using 3DCRT, 3/10 patients could not be treated with TD > 50 Gy, but 9/10 patients get higher TD by IMRT. TD to the PTV1 could be escalated by 16% on average. The use of non-coplanar fields in IMRT lead to a reduction of the irradiated lung volume. There is a strong correlation between physical and biological mean lung doses.
Conclusion: IMRT gives the possibility of further dose escalation without an increasing mean lung dose especially in patients with large tumors.
Similar articles
-
Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):561-70. doi: 10.1016/j.ijrobp.2005.02.011. Int J Radiat Oncol Biol Phys. 2005. PMID: 15890601 Clinical Trial.
-
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1258-67. doi: 10.1016/j.ijrobp.2003.09.086. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001271
-
Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. doi: 10.1016/j.ijrobp.2005.03.012. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15927412
-
Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy.Clin Lung Cancer. 2006 Nov;8(3):195-202. doi: 10.3816/CLC.2006.n.047. Clin Lung Cancer. 2006. PMID: 17239295 Review.
-
[Inoperable non-small-cell bronchial carcinoma: macroscopic and microscopic tumor behavior during and after radiotherapy with curative intent].Praxis (Bern 1994). 1999 Oct 28;88(44):1825-36. Praxis (Bern 1994). 1999. PMID: 10584553 Review. German.
Cited by
-
Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.Strahlenther Onkol. 2011 Jan;187(1):45-51. doi: 10.1007/s00066-010-2116-3. Epub 2010 Dec 23. Strahlenther Onkol. 2011. PMID: 21234531
-
Dosimetric comparison of coplanar and noncoplanar beam arrangements for radiotherapy of patients with lung cancer: A meta-analysis.J Appl Clin Med Phys. 2021 Apr;22(4):34-43. doi: 10.1002/acm2.13197. Epub 2021 Feb 26. J Appl Clin Med Phys. 2021. PMID: 33634946 Free PMC article.
-
Measurement of the interplay effect in lung IMRT treatment using EDR2 films.J Appl Clin Med Phys. 2006 Nov 28;7(4):33-42. doi: 10.1120/jacmp.v7i4.2222. J Appl Clin Med Phys. 2006. PMID: 17533350 Free PMC article.
-
Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Transl Lung Cancer Res. 2017 Apr;6(2):131-147. doi: 10.21037/tlcr.2017.04.04. Transl Lung Cancer Res. 2017. PMID: 28529896 Free PMC article. Review.
-
Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.Balkan Med J. 2014 Dec;31(4):286-94. doi: 10.5152/balkanmedj.2014.14529. Epub 2014 Sep 13. Balkan Med J. 2014. PMID: 25667781 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical